BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
2019
323
Last FY Revenue $25.1M
Last FY EBITDA $0.9M
$2.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, BGM Group achieved revenue of $25.1M and an EBITDA of $0.9M.
BGM Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See BGM Group valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $25.1M | XXX | XXX | XXX |
Gross Profit | XXX | $4.1M | XXX | XXX | XXX |
Gross Margin | XXX | 16% | XXX | XXX | XXX |
EBITDA | XXX | $0.9M | XXX | XXX | XXX |
EBITDA Margin | XXX | 4% | XXX | XXX | XXX |
EBIT | XXX | -$0.4M | XXX | XXX | XXX |
EBIT Margin | XXX | -1% | XXX | XXX | XXX |
Net Profit | XXX | -$1.4M | XXX | XXX | XXX |
Net Margin | XXX | -6% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, BGM Group's stock price is $13.
BGM Group has current market cap of $2.5B, and EV of $2.4B.
See BGM Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.4B | $2.5B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, BGM Group has market cap of $2.5B and EV of $2.4B.
BGM Group's trades at 97.4x EV/Revenue multiple, and 2778.9x EV/EBITDA.
Equity research analysts estimate BGM Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BGM Group's P/E ratio is not available.
See valuation multiples for BGM Group and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $2.5B | XXX | $2.5B | XXX | XXX | XXX |
EV (current) | $2.4B | XXX | $2.4B | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 97.4x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | 2778.9x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -6842.1x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -1707.2x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -721.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBGM Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $14K for the same period.
BGM Group's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BGM Group's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for BGM Group and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $14K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BGM Group acquired XXX companies to date.
Last acquisition by BGM Group was XXXXXXXX, XXXXX XXXXX XXXXXX . BGM Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was BGM Group founded? | BGM Group was founded in 2019. |
Where is BGM Group headquartered? | BGM Group is headquartered in United States of America. |
How many employees does BGM Group have? | As of today, BGM Group has 323 employees. |
Who is the CEO of BGM Group? | BGM Group's CEO is Mr. Chen Xin. |
Is BGM Group publicy listed? | Yes, BGM Group is a public company listed on NAS. |
What is the stock symbol of BGM Group? | BGM Group trades under BGM ticker. |
When did BGM Group go public? | BGM Group went public in 2021. |
Who are competitors of BGM Group? | Similar companies to BGM Group include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of BGM Group? | BGM Group's current market cap is $2.5B |
Is BGM Group profitable? | Yes, BGM Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.